CareDx, Inc (CDNA) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 10 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for CDNA is $23.33, representing a +32.3% upside from the current price of $17.63. Price targets range from a low of $18.00 to a high of $26.00.
